Article
Engineered coagulation factor VIII with enhanced secretion and coagulation potential for…
medRxiv · 2024 · Kashiwakura, Y.; Nakajima, Y.; Horinaka, K.; Lopes, T. J. d. S.; Furuta, Y.; Yamaguchi, Y.; Baatartsogt, N.; Hayakawa, M.; Katakai, Y.; Uchiyama, S.; Nureki, O.; Nogami, K.; Ohmori, T.
Key facts
| Title | Engineered coagulation factor VIII with enhanced secretion and coagulation potential for hemophilia A gene therapy |
|---|---|
| First author | Kashiwakura, Y.; Nakajima, Y.; Horinaka, K.; Lopes, T. J. d. S.; Furuta, Y.; Yamaguchi, Y.; Baatartsogt, N.; Hayakawa, M.; Katakai, Y.; Uchiyama, S.; Nureki, O.; Nogami, K.; Ohmori, T. |
| Journal | medRxiv |
| Published | Jan 1, 2024 |
| DOI | 10.1101/2024.12.05.626963 |
| Devices mentioned | K070531 |
| Product codes mentioned | CGZ, JJH, LXG |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1